Skip to main content
. 2004 Jul 19;2004(3):CD001720. doi: 10.1002/14651858.CD001720.pub2

Schneider 1981.

Methods Allocation: randomised. 
 Blindness: double. 
 Duration: 1 year (preceeded by 2 week wash‐out).
Participants Diagnosis: schizophrenia (DSM II). 
 History: duration ill mean 21 years, informed consent. 
 N=59. 
 Age: mean 45 years, range 21‐65. 
 Sex: 51M, 8F. 
 Setting: not reported.
Interventions 1. Pipothiazine palmitate: dose range 50‐40 mg/IM/2‐5 weeks. N=32. 
 2. Fluphenazine decanoate: dose range 12.5‐100 mg/IM/2‐5 weeks. N=27.
Outcomes Leaving the study early.
Unable to use ‐ 
 Global impression: CGI (no data). 
 Blood samples: (no usable data).
Notes 67% attrition occured in the control group by the end of 1year, therefore data could not be used.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear